|Awarded On||May 18, 2016|
|Title||A "Pap smear" for ovarian cancer|
|Award Mechanism||High Impact/High Risk|
|Institution/Organization||Baylor College of Medicine|
|Principal Investigator/Program Director||Laising Yen|
Ovarian cancer is the most lethal gynecologic malignancy, and women with ovarian cancer continue to have an unacceptable 5-year survival rate of only 31%. This low survival rate has barely changed during the last three decades, indicating that we have not yet made the major advances necessary to win the “War on Ovarian Cancer”. The major reason for the low rates of survival is that most patients are diagnosed at an advanced stage, because there is no useful screening test for ovarian cancer. None! Detecting the cancer early enough to be surgically treatable would greatly reduce mortality. Our proposal is designed with this in mind. We aim to leverage the existing cervical Pap smear screening...